Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea

Pneumococcal disease poses a substantial clinical and economic burden, especially among children under 5 years old. The 13-valent pneumococcal conjugate vaccine (PCV13) was first introduced in South Korea’s Childhood Immunization Program in 2014. In October 2023, the Ministry of Food and Drug Safety...

書誌詳細
出版年:	Human Vaccines & Immunotherapeutics
主要な著者:	Young June Choe, Yunjin Jeon, Jihyun Park, Hyesun Kim, Gyongseon Yang, Salini Mohanty, Lefteris Floros, Min Huang, Nitika Chhabra, Shalini Kumari, Jasmeet Singh, Isaya Sukarom
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2025-12-01
主題:	Invasive pneumococcal disease Streptococcus pneumoniae bacteremic pneumococcal pneumonia acute otitis media
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/21645515.2025.2515650

類似資料

A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015
著者:: Ting-An Yen, 等
出版事項: (2025-02-01)

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population
著者:: Stéphane Fiévez, 等
出版事項: (2025-08-01)

Clinical burden of pneumococcal disease among adults in France: A retrospective cohort study
著者:: M. Doyinsola Bailey, 等
出版事項: (2025-12-01)

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong
著者:: Salini Mohanty, 等
出版事項: (2022-11-01)

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study
著者:: Luis A. Ruiz, 等
出版事項: (2017-06-01)

Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico
著者:: Matthew Wasserman, 等
出版事項: (2019-03-01)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
著者:: Hye-Young Kim, 等
出版事項: (2021-03-01)

Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness
著者:: Vincenzo Restivo, 等
出版事項: (2023-07-01)

Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective cohort study
著者:: Nicole Cossrow, 等
出版事項: (2025-07-01)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
著者:: Thomas Chandler, 等
出版事項: (2022-03-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
著者:: Antoni Payeras, 等
出版事項: (2015-04-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
著者:: A. L. Perova, 等
出版事項: (2014-09-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
著者:: Ching-Fen Shen, 等
出版事項: (2021-09-01)

Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
著者:: Miguel Gouveia, 等
出版事項: (2019-04-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
著者:: Salil Bendre, 等
出版事項: (2024-02-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
著者:: Salil Bendre, 等
出版事項: (2024-02-01)

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
著者:: Michael Pichichero, 等
出版事項: (2023-12-01)

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
著者:: Germaine Hanquet, 等
出版事項: (2022-01-01)

Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014–2018
著者:: Tianyan Hu, 等
出版事項: (2023-04-01)

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines
著者:: Oana Falup-Pecurariu
出版事項: (2012-12-01)

What do Patients Know About Pneumococcal Vaccine?
著者:: Fatma Çiftci, 等
出版事項: (2017-08-01)

Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan
著者:: Kosuke Tamura, 等
出版事項: (2024-06-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
著者:: Ching-Fen Shen, 等
出版事項: (2013-09-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
著者:: Cornelis H. van Werkhoven
出版事項: (2017-05-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
著者:: I. N. Protasova, 等
出版事項: (2021-12-01)

Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
著者:: S. M. Kharit, 等
出版事項: (2016-12-01)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants
著者:: Sophie Warren, 等
出版事項: (2023-08-01)

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
著者:: Felicitas Kühne, 等
出版事項: (2023-12-01)

Estimation of 13-valent Pneumococcal Conjugate Vaccine Efficiency in Infants within National Immunization Schedule
著者:: Nikolay I. Briko, 等
出版事項: (2019-09-01)

Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review
著者:: Patricia Izurieta, 等
出版事項: (2025-05-01)

Strategies for pneumococcal vaccination in older adults in the coming era
著者:: Kei Nakashima, 等
出版事項: (2024-12-01)

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
著者:: Aurelija Petrutienė, 等
出版事項: (2025-08-01)

A Multicomponent Intervention to Improve Pneumococcal Vaccination Knowledge Among Internal Medicine Residents
著者:: Matthew W. Wilson, 等
出版事項: (2016-06-01)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
著者:: Brita Askeland Winje, 等
出版事項: (2021-08-01)

Streptococcus pneumoniae serotype distribution in Bangladeshi under-fives with community-acquired pneumonia pre-10-valent pneumococcal conjugate vaccination
著者:: Stefan M. T. Vestjens, 等
出版事項: (2024-11-01)

Global distribution and characteristics of pneumococcal serotypes in adults
著者:: Haruka Maeda, 等
出版事項: (2025-12-01)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
著者:: Andrew D. Wiese, 等
出版事項: (2019-04-01)

A brief history of and future prospects for pneumococcal vaccination in Malaysia
著者:: Alex J. J. Lister, 等
出版事項: (2023-08-01)

Recent progress in pneumococcal protein vaccines
著者:: Sha Li, 等
出版事項: (2023-09-01)

Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines
著者:: Ninecia R. Scott, 等
出版事項: (2021-03-01)